- Home
- DJCO vs SLP Comparison
DJCO vs SLP Comparison
Compare DJCO & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DJCO
- SLP
- Stock Information
- Founded
- DJCO 1987
- SLP 1996
- Country
- DJCO United States
- SLP United States
- Employees
- DJCO N/A
- SLP N/A
- Industry
- DJCO Newspapers/Magazines
- SLP EDP Services
- Sector
- DJCO Consumer Discretionary
- SLP Technology
- Exchange
- DJCO Nasdaq
- SLP Nasdaq
- Market Cap
- DJCO 793.7M
- SLP 708.1M
- IPO Year
- DJCO N/A
- SLP 1997
- Fundamental
- Price
- DJCO $397.88
- SLP $30.16
- Analyst Decision
- DJCO
- SLP Buy
- Analyst Count
- DJCO 0
- SLP 8
- Target Price
- DJCO N/A
- SLP $47.83
- AVG Volume (30 Days)
- DJCO 6.6K
- SLP 473.5K
- Earning Date
- DJCO 05-20-2025
- SLP 07-01-2025
- Dividend Yield
- DJCO N/A
- SLP 0.20%
- EPS Growth
- DJCO 370.42
- SLP N/A
- EPS
- DJCO 55.48
- SLP 0.36
- Revenue
- DJCO $71,642,000.00
- SLP $78,564,000.00
- Revenue This Year
- DJCO N/A
- SLP $30.38
- Revenue Next Year
- DJCO N/A
- SLP $11.97
- P/E Ratio
- DJCO $7.06
- SLP $84.56
- Revenue Growth
- DJCO 0.34
- SLP 21.49
- 52 Week Low
- DJCO $359.34
- SLP $23.01
- 52 Week High
- DJCO $602.00
- SLP $51.22
- Technical
- Relative Strength Index (RSI)
- DJCO 57.11
- SLP 45.75
- Support Level
- DJCO $367.24
- SLP $27.85
- Resistance Level
- DJCO $381.31
- SLP $30.78
- Average True Range (ATR)
- DJCO 7.42
- SLP 1.58
- MACD
- DJCO 2.60
- SLP -0.74
- Stochastic Oscillator
- DJCO 100.00
- SLP 26.86
About DJCO Daily Journal Corp. (S.C.)
Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Journal Technologies segment.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.